Support for HCPs
TOFIDENCE
Dossier
TOFIDENCE Dossier
Biogen’s scientific & manufacturing expertise has enabled the production of several biosimilars of advanced biologics. This comprehensive resource provides detailed information on TOFIDENCE and guides you through the portfolio of Biogen’s biosimilars. It contains all the information you need to know in order to successfully implement the biosimilars in your clinical practice.
Biogen
Global Website
Biogen Global Website
Biogen has long been a pioneer in the anti-TNF biosimilar space, leading research into innovative medicines and efficiently bringing them to market to transform patient lives. Biogen is opening doors to treatment for more patients: The introduction of anti-TNF biosimilars has resulted in a 97% volume growth of the market up to 2021.1
Visit our website to find out more about our commitment to patients and to sustainable healthcare as well as to keep up-to-date with our latest developments.
Biosimilars
Medical Academy
Biosimilars Medical Academy
This exclusive HCP educational resource houses key information to further understand biosimilars and their clinical use. Click here to access high quality educational content which can help bring you up to speed on any areas of interest you may have regarding biosimilars. As this is a continually updated resource, clinicians are invited to refer to the Biosimilars Medical Academy regularly.
Help start a movement for more patients
You also might be interested in:
Abbreviations: HCP, healthcare professional; TNF, tumour necrosis factor.
